Newsroom
Sorted by: Latest
-
Sidecar Health Supports CMS Decision to Remove Network Requirement for ACA Exchange Plans
CLEVELAND--(BUSINESS WIRE)--Sidecar Health Supports CMS Decision to Remove Network Requirement for ACA Exchange Plans....
-
Enhertu® Approved in the U.S. for Two New Indications for Patients with HER2 Positive Early Breast Cancer
TOKYO--(BUSINESS WIRE)--Enhertu Approved in the U.S. for Two New Indications for Patients with HER2 Positive Early Breast Cancer...
-
Liberty Broadband Corporation Declares Quarterly Cash Dividend on Series A Cumulative Redeemable Preferred Stock
ENGLEWOOD, Colo.--(BUSINESS WIRE)--Liberty Broadband Corporation Declares Quarterly Cash Dividend on Series A Cumulative Redeemable Preferred Stock...
-
Cotchett, Pitre & McCarthy Announces Federal Court Grants Final Approval of “Historic” Discrimination Settlement with Wells Fargo
SAN FRANCISCO--(BUSINESS WIRE)--Cotchett, Pitre & McCarthy announces today, May 15, 2026, Judge Trina Thompson of the United States District Court in the Northern District of California granted final approval of the historic $110 million settlement reached in In re Wells Fargo & Co. Consolidated Derivative Shareholder Litigation, a seminal derivative lawsuit brought by Wells Fargo shareholders that essentially combined two cases into one, and alleged that the Bank’s Board of Directors b...
-
Pyxis Group et Principia Consulting créent une joint-venture stratégique pour renforcer leurs services de conseil et leur offre technologique à l'échelle mondiale
HOUSTON--(BUSINESS WIRE)--Pyxis Group et Principia Consulting ont annoncé aujourd'hui la création d'une joint-venture stratégique qui desservira les marchés mondiaux des matières premières et de l'énergie. Ce partenariat permet de réunir deux entreprises très spécialisées dont les compétences viennent se compléter. Cette joint-venture propose une offre combinée qui couvre l'ensemble des besoins des sociétés de négoce de matières premières, des entreprises énergétiques et des établissements fina...
-
Boxlight Reports First Quarter 2026 Financial Results
DULUTH, Ga.--(BUSINESS WIRE)--Boxlight Corporation (Nasdaq: BOXL) (“Boxlight” or the “Company”), a leading provider of interactive technology solutions, today announced the Company’s financial results for the first quarter ended March 31, 2026. Financial and Operational Highlights: Revenue was $22.4 million for the quarter, an increase of 0.1% from the prior year quarter Gross profit margin in Q1’26 decreased to 30.9% from 35.9% from the prior year quarter Net loss was $(6.5) million, compared...
-
Rosen Law Firm Encourages Option Care Health, Inc. Investors to Inquire About Securities Class Action Investigation – OPCH
NEW YORK--(BUSINESS WIRE)--Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Option Care Health, Inc. (NASDAQ: OPCH) resulting from allegations that Option Care Health, Inc. may have issued materially misleading business information to the investing public. So What: If you purchased Option Care Health, Inc. securities you may be entitled to compensation without payment of any out of pocket fees or costs...
-
USA Compression Partners Announces 2025 K-3 Tax Package Availability
DALLAS--(BUSINESS WIRE)--USA Compression Partners, LP (NYSE: USAC) (“USA Compression”) today announced that its 2025 Schedule K-3 reflecting items of international tax relevance is available online. Unitholders requiring this information may access their Schedule K-3 at taxpackagesupport.com/usac. A limited number of unitholders (primarily foreign unitholders, unitholders computing a foreign tax credit on their tax return and certain corporate and/or partnership unitholders) may need the detail...
-
Republic Technologies Provides Bi-Weekly Update On Annual Filings
VANCOUVER, British Columbia--(BUSINESS WIRE)--Republic Technologies Inc. (CSE: DOCT) (FSE: 7FM0) (OTCQB: DOCKF) ("Republic" or the "Company") today provided an update with respect to its previously announced management cease trade order ("MCTO") in connection with the Company's filing of its audited annual financial statements (the " Financial Statements") and management discussion and analysis (the "MD&A") for the financial year ended December 31, 2025, and the applicable CEO and CFO certi...
-
United Therapeutics Corporation Announces FDA Clearance to Proceed with UHeart Xenotransplantation Clinical Trial
SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, today announced that the U.S. Food and Drug Administration (FDA) has granted clearance under the company’s Investigational New Drug application to proceed with a clinical study of its investigational UHeart™ derived from a pig with 10 gene edits. The study, known as EXPRESS, will enroll an initial cohort of up to two participants. United Therapeutics...